ArticleActa oncologica (Stockholm, Sweden)2024

Real-life experience with sorafenib for advanced and refractory desmoid-type fibromatosis.

Delphine Schampers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.